{"result": "(\"entity\"<|>ÁNGELA GONZÁLEZ DÍAZ-FAES<|>PERSON<|>Ángela González Díaz-Faes is a specialist in Endocrinology and Nutrition at Hospital Universitario Marqués de Valdecilla in Santander.)\n##\n(\"entity\"<|>HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA<|>ORGANIZATION<|>Hospital Universitario Marqués de Valdecilla is a hospital located in Santander, specializing in various medical fields including endocrinology and nutrition.)\n##\n(\"entity\"<|>CARCINOMA EPIDERMOIDE<|>EVENT<|>Carcinoma epidermoide is a type of cancer diagnosed in the patient, specifically affecting the right hemilengua.)\n##\n(\"entity\"<|>DIABETES MELLITUS TIPO 2<|>EVENT<|>Diabetes mellitus tipo 2 is a chronic condition affecting the patient, characterized by insulin resistance and high blood sugar levels.)\n##\n(\"entity\"<|>MAXILOFACIAL<|>ORGANIZATION<|>Maxilofacial refers to the department or specialty dealing with facial and jaw-related medical issues, where the patient was referred for nutritional assessment.)\n##\n(\"entity\"<|>CEX DE MAXILOFACIAL<|>ORGANIZATION<|>CEX de Maxilofacial is a clinical evaluation center specializing in maxillofacial conditions.)\n##\n(\"entity\"<|>TAC CUELLO<|>EVENT<|>TAC cuello refers to a CT scan of the neck performed to assess the lesion in the patient's tongue.)\n##\n(\"entity\"<|>ODINOFAGIA<|>EVENT<|>Odinofagia is a medical condition characterized by pain during swallowing, which the patient is experiencing.)\n##\n(\"entity\"<|>NUTRICIÓN<|>EVENT<|>Nutrición refers to the nutritional assessment and support provided to the patient, particularly in the context of cancer treatment.)\n##\n(\"relationship\"<|>ÁNGELA GONZÁLEZ DÍAZ-FAES<|>HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA<|>Ángela González Díaz-Faes works as a specialist at Hospital Universitario Marqués de Valdecilla<|>9)\n##\n(\"relationship\"<|>HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA<|>MAXILOFACIAL<|>The hospital has a maxillofacial department where the patient was referred for evaluation<|>5)\n##\n(\"relationship\"<|>MAXILOFACIAL<|>CEX DE MAXILOFACIAL<|>The CEX de Maxilofacial is a clinical evaluation center associated with the maxillofacial department<|>5)\n##\n(\"relationship\"<|>CARCINOMA EPIDERMOIDE<|>NUTRICIÓN<|>Nutritional support is critical for patients diagnosed with carcinoma epidermoide<|>8)\n##\n(\"relationship\"<|>DIABETES MELLITUS TIPO 2<|>NUTRICIÓN<|>Nutritional management is essential for patients with diabetes mellitus tipo 2<|>8)\n##\n(\"relationship\"<|>ODINOFAGIA<|>NUTRICIÓN<|>Odinofagia affects the patient's ability to eat, necessitating nutritional support<|>7)\n##\n(\"relationship\"<|>TAC CUELLO<|>CARCINOMA EPIDERMOIDE<|>The TAC cuello was performed to assess the carcinoma epidermoide in the patient's tongue<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Barthelemy , Hartmut Bertz , Federico\nBozzetti , et al. ESPEN guidelines on nutrition in cancer patients*. Clin Nutr. 2017; 36:11-48.\n\n\n\n3. M. Planas, J.F. Fernández-Ortega y J. Abilés. Recomendaciones para el soporte nutricional y me-\ntabólico especializado del paciente crítico. Actualización. Consenso SEMICYUC-SENPE: Paciente on-\ncohematológico. Medicina Intensiva. 2011;35(Supl. 1):53-6.\n\n\n\n4. Perez Pitarch A, Guglieri Lopez B, Nacher A, Merino V. Impact of undernutrition on the Pharmaco-\nkinetics and Pharmacodynamics of anticancer drugs. A Literature Review. Nutrition and Cancer. 2017;\n69 (4): 555-63.\n\n\n\n5. Gluud Lise L, Dam G, Les I, Córdoba J, Marchesini G, Borre M, et al. Branched-chain amino acids for\npeople with hepatic encephalopathy. Cochrane Database Syst Rev. 2015; 10.1002/14651858.CD001939.\npub2.\n\n\n\n6. Rivera Irigoin R1, Abilés J. Nutritional support in patients with liver cirrhosis. Gastroenterol Hepa-\ntol. 2012 Oct;35(8):594-601. doi: 10.1016/j.gastrohep.2012.03.001. Epub 2012 May 30.\n\n\n\n                                                                                                               155\n---\n       Caso Clínico\n     Soporte nutricional en paciente diabético\n     con cáncer de cabeza y cuello\n     Dra. Ángela González Díaz-Faes\n     Médico Especialista en Endocrinología y Nutrición.\n     Hospital Universitario Marqués de Valdecilla. Santander.\n\n\n\n     Resumen\n             Varón de 66 años con diabetes            mellitus tipo 2, con regular control crónico,\n     diagnosticado de carcinoma epidermoide de hemilengua derecha y desnutrición calórico\n     proteica moderada grave asociada.\n\n\n\n     Palabras clave\n             Diabetesmellitus, desnutrición, cáncer.\n\n\n\n     Caso clínico\n             Varón de 66 años de edad, que acude a la consulta de Nutrición, derivado desde\n     Maxilofacial para valoración nutricional.\n\n\n\n             Como antecedentes personales, no presenta alergias medicamentosas conocidas,\n     es fumador de 1 paquete al día y consumidor de OH de 40 gr al día. Presenta hiperten-\n     sión arterial, dislipemia, diabetesmellitus tipo 2, de 10 años de evolución, con regular\n     control glucometabólico crónico, actualmente en tratamiento con metformina 850 mg\n     cada 12 horas e insulina Glargina 28-0-0 UI al día, sin complicaciones conocidas ni\n     macro ni microvasculares.\n\n\n\n             Tratamiento habitual: olmesartán 20 mg, atorvastatina 40 mg, metformina\n     850 mg cada 12 horas, insulina glargina 28-0-0 UI.\n\n\n\n             Presenta cuadro clínico de 3 meses de evolución consistente en bultoma en\n     hemilengua derecha, odinofagia que ha ido aumentando de intensidad, así como dolor\n     irradiado a oído derecho.\n\n\n\n             Asocia pérdida de peso de 10 kilos, que parece haberse iniciado antes de comenzar\n     con la odinofagía.\n\n\n\n156\n---\n          Valorado en CEX de maxilofacial previamente, donde se realizan las siguientes\npruebas complementarias:\n\n\n\n          Biopsia de la lesión\n\n\n\n          TAC cuello: lesión en lengua de 2,5 cm en borde anteroposterior que afecta a la\nparte más posterior de la porción bucal de la lengua. No se aprecian adenopatías cervi-\ncales de aspecto patológico.\n\n\n\n          Datos analíticos: glucosa 192 mg/dl, cretinina 1,8 mg/dl, FG 54 ml/min/1 proteinas\ntotales 5,7 g/dl, albúmina 3,1 g/dl, prealbúmina 15, CT 163 mg/dl, HbA1c 8,2%, Hb 12,8 gr/dl,\nlinfocitos 3,2 mil/mm3 .\n          Valoración en Comité de tumores: con el diagnóstico de carcinoma epidermoide de\nlengua pT2N0M0, se plantea realización de intervención quirúrgica y posteriormente\ntratamiento con radioterapia.\n\n\n\n          Valoración nutricional\n\n\n\n-Datos relativos a la ingesta: dieta diabética blanda con ingesta del 50-75% de la ración,\npor odinofagía e hiporexia.\n\n\n\n-Datos antropométricos:\n         •Peso actual: 62 kilos.\n         •Talla: 170 cm.\n         •IMC (índice de masa corporal): 21 kg/m\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}